Mentions
Extended reach
Total likes
Video views
AI synopsis
Participants in the discussions mentioned key study details, like the 49% improvement in disruptive behavior observed with the whole-plant extract versus 21% on placebo, using terms like 'important' and 'proof that is acceptable' to underline their points. The tone varies from optimistic to critical, with some users expressing skepticism about the product integrity and the need for more rigorous research, showing a mix of excitement about the potential benefits and caution regarding the evidence.
Many discussions reflect a cautious acceptance of the findings, with users acknowledging both potential benefits and concerns.
There is considerable curiosity about the study's implications for autism treatment, with several users expressing direct interest in cannabinoid treatments.
Discussions highlight various aspects of the study, including its methodologies and outcomes, but some posts show skepticism regarding the robustness of evidence provided.
Users generally believe the findings could significantly influence future research and treatment options for autism.
やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻 ＃自閉症 ＃ASD https://t.co/DvgkHCw4uZ https://t.co/nGhYqII4a9
Cannabis can be effective for autism, but the whole plant seems to work best. Disruptive behaviour scores were improved 49% of the participants who took the whole plant extract, 37% of pure extract, and 21% of those who took the placebo. https://t.co/5dKyDiSTvl
#Cannabinoid treatment for #autism: A proof-of-concept randomized trial https://t.co/lTIx5f67Jw Attn: @_atanas_ @_INPST @ScienceCommuni2 @drmikehart @zivacooper @AutismFreeBrain @thinkingautism @AutismNewsNet @ASN_tweet @cannabist
more good news re: cannabis and autism. this is whole plant, 20:1 ratio CBD:THC. https://t.co/iwt19ITFD4
Mixed results for 3-arm N=150 RCT of (hyped) cannabinoids for autistics aged 5-21 https://t.co/9j55tFU0pe changes to planned outcomes, big COIs, free
Cannabinoid treatment for autism: a proof-of-concept randomized trial https://t.co/vH0uLa1AfJ https://t.co/qFfPkZBrmA
Canabidiol no tratamento do autismo: mito ou realidade. Recent studies suggest that cannabidiol may improve symptoms in 49% of children with Autism Spectrum Disorder. This video features Professor Lucelmo Lacerda…
In this video, we explore the use of CBD (cannabidiol) for treating symptoms of Autism Spectrum Disorder (ASD). A randomized trial showed that nearly half of participants experienced significant improvement in…
In this episode of EfectoSquito, we explore the clinical use of cannabinoids for Autism Spectrum Disorder (ASD). Discussing a randomized trial, we delve into the efficacy of whole-plant cannabis extracts versus purified…
Severe autism is a neurological disorder affecting social development and communication. This video explores the effects of cannabinoid treatments on behavioral issues in autism, highlighting the potential for…
As a Behaviour Specialist and Paediatric Sleep Practitioner, I analyze research on cannabinoid treatments for behavioral problems in children with autism. This video discusses a randomized trial revealing significant…
This video explores the potential benefits of Cannabis sativa as an alternative treatment to alleviate symptoms related to Autism Spectrum Disorder (ASD). The systematic review highlights its efficacy in reducing…
Autismul Și Soluția ! Studiile Și Exemplele O Spun ! https://t.co/jN6fhnFLfn a través de @YouTube
@NeuroRebel https://t.co/VboybhbLgU
https://t.co/VCFDuhobMA Cannabinoid treatment for autism: a proof-of-concept randomized trial
@mdreddy6 1. re the familiar narrative, we have not come a long way 2. some research: recent systematic review https://t.co/17tzhYDryC the sole (?) RCT so far https://t.co/1JddTddWEP with big COIs & tons of pre-trial hype (not good) some trial registrations https://t.co/0D6LZ3eiGT
This may be promising despite limitations of the study. Product integrity a concern here. Give us a purified, tested, and proven cannabis-based medication, all good. Not garbage made in someones garage or basement. https://t.co/qEQD1I63M4
@AgainstCures @RodMakeKidsBald @CaulfieldTim @gorskon @drsanjaygupta @CNN We agree that there is not a lot of good evidence out there for cannabis products therapeutically. We don't have any studies currently in autism, but it is a question we get asked a lot. There is some emerging data that signal benefit from https://t.co/qg0J0Fe1hs
https://t.co/nIgsDjjtYX @Athens4Cannabis #cannabis #cannabiscommunity #lifestyle #weed #marijuana #thc #motivation #cannabisculture #cbd #weedporn #autism #hightimes #stoner #indica #sativa #hemp #maryjane #medicalmarijuana #ganja #kush #highlife #dabs #dank #cannabissociety
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
RT @yuji_masataka: やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻…
やはり全草こそ至高。 イスラエルで自閉症患者に①全草抽出CBD:THC=20:1（赤） ②精製CBD:THC=1:1（グレー）を投与しプラセボと比較したところ、認容性は良好で全草では半分の患者で問題行動の改善が得られました。 ＃医療大麻 ＃自閉症 ＃ASD https://t.co/DvgkHCw4uZ https://t.co/nGhYqII4a9
@Spectrum Kind of distressing: “Disruptive behavior on the CGI-I (co-primary outcome) was either much or very much improved in 49% on whole-plant extract (n = 45) versus 21% on placebo (n = 47; p = 0.005).” Drug us so we don’t “disrupt”? https://t.co/uVT01W11vB
RT @C4T_Canada: A recent article caught our attention in the @MolecularAutism – “ #Cannabinoid treatment for #autism: a proof-of-concept ra…
A recent article caught our attention in the @MolecularAutism – “ #Cannabinoid treatment for #autism: a proof-of-concept randomized trial" https://t.co/qg0J0Fe1hs
RT @patientsfirstcd: Cannabinoid treatment for autism: a proof-of-concept randomized trial https://t.co/PIly1ImVc4 #Autism #MedicalCannabis…
Cannabinoid treatment for autism: a proof-of-concept randomized trial https://t.co/PIly1ImVc4 #Autism #MedicalCannabis #MedEd
RT @drmikehart: Cannabis can be effective for autism, but the whole plant seems to work best. Disruptive behaviour scores were improved 4…
RT @drmikehart: Cannabis can be effective for autism, but the whole plant seems to work best. Disruptive behaviour scores were improved 4…
RT @drmikehart: Cannabis can be effective for autism, but the whole plant seems to work best. Disruptive behaviour scores were improved 4…
Cannabis can be effective for autism, but the whole plant seems to work best. Disruptive behaviour scores were improved 49% of the participants who took the whole plant extract, 37% of pure extract, and 21% of those who took the placebo. https://t.co/5dKyDiSTvl
Cannabinoid treatment for autism: a proof-of-concept randomized trial - PubMed https://t.co/0XPAfE3qWQ
自閉症のカンナビノイド治療：概念実証ランダム化試験。 https://t.co/ZZ19LmDFaF https://t.co/qukJGVRK5h #ヘンプ #ＣＢＤ #カンナビジオール #科学的根拠
Cannabinoid treatment for autism: a proof-of-concept randomized trial. https://t.co/ZZ19LmDFaF #Hemp #CBD #CB2
No evidence for the efficacy of Cannabinoid treatment for autism (except the expected drowsiness) https://t.co/40Gv5osw7U
Cannabinoid treatment for autism: a proof-of-concept randomized trial. https://t.co/ffKyq43fg1
RT @MolecularAutism: Cannabinoid treatment for autism: a proof-of-concept randomized trial https://t.co/vH0uLa1AfJ https://t.co/qFfPkZBrmA
RT @HealthyFellow: #Cannabinoid treatment for #autism: A proof-of-concept randomized trial https://t.co/lTIx5f67Jw Attn: @_atanas_ @_INPST…
RT @HealthyFellow: #Cannabinoid treatment for #autism: A proof-of-concept randomized trial https://t.co/lTIx5f67Jw Attn: @_atanas_ @_INPST…
RT @HealthyFellow: #Cannabinoid treatment for #autism: A proof-of-concept randomized trial https://t.co/lTIx5f67Jw Attn: @_atanas_ @_INPST…
RT @HealthyFellow: #Cannabinoid treatment for #autism: A proof-of-concept randomized trial https://t.co/lTIx5f67Jw Attn: @_atanas_ @_INPST…
Cannabinoid treatment for autism: a proof-of-concept randomized trial https://t.co/cQLopgHMJo
RT @HealthyFellow: #Cannabinoid treatment for #autism: A proof-of-concept randomized trial https://t.co/lTIx5f67Jw Attn: @_atanas_ @_INPST…
RT @HealthyFellow: #Cannabinoid treatment for #autism: A proof-of-concept randomized trial https://t.co/lTIx5f67Jw Attn: @_atanas_ @_INPST…
Cannabis Research: Cannabinoid treatment for autism: a proof-of-concept randomized trial "We tested.. a whole-plant cannabis extract containing cannabidiol & Δ9-tetrahydrocannabinol at a 20:1.. purified cannabidiol & Δ9-THC at the same ratio." #Cannabis https://t.co/mAuqlqJDHP
RT @HealthyFellow: #Cannabinoid treatment for #autism: A proof-of-concept randomized trial https://t.co/lTIx5f67Jw Attn: @_atanas_ @_INPST…
WE all knew this but now WE have proof that is acceptable... https://t.co/TlY9kjCW7e
RT @HealthyFellow: #Cannabinoid treatment for #autism: A proof-of-concept randomized trial https://t.co/lTIx5f67Jw Attn: @_atanas_ @_INPST…
#Cannabinoid treatment for #autism: A proof-of-concept randomized trial https://t.co/lTIx5f67Jw Attn: @_atanas_ @_INPST @ScienceCommuni2 @drmikehart @zivacooper @AutismFreeBrain @thinkingautism @AutismNewsNet @ASN_tweet @cannabist
Cannabinoid treatment for autism: a proof-of-concept randomized trial. https://t.co/Tw2EGeE12I #PubMed #Autism
RT @BellevueDoc: more good news re: cannabis and autism. this is whole plant, 20:1 ratio CBD:THC. https://t.co/iwt19ITFD4
more good news re: cannabis and autism. this is whole plant, 20:1 ratio CBD:THC. https://t.co/iwt19ITFD4
Cannabinoid treatment for autism: a proof-of-concept randomized trial. https://t.co/ZZPGeeZa35
Cannabinoid treatment for autism: a proof-of-concept randomized trial. https://t.co/chjajXUXFh
Mixed results for 3-arm N=150 RCT of (hyped) cannabinoids for autistics aged 5-21 https://t.co/9j55tFU0pe changes to planned outcomes, big COIs, free
Placebo-controlled trial. Grounds for quite a bit more work in this area: Cannabinoid treatment for autism: a proof-of-concept randomized trial. https://t.co/LPJHiKRY6B
Cannabinoid treatment for autism: a proof-of-concept randomized trial https://t.co/vH0uLa1AfJ https://t.co/qFfPkZBrmA
RT @mengchuanlai: Really important @MolecularAutism double-blind placebo-controlled RCT that examines whether cannabinoid helps autistic ch…
RT @mengchuanlai: Really important @MolecularAutism double-blind placebo-controlled RCT that examines whether cannabinoid helps autistic ch…
Really important @MolecularAutism double-blind placebo-controlled RCT that examines whether cannabinoid helps autistic children and youth (5-21 y/o). https://t.co/5R4K8ycd6q